Chronic traumatic encephalopathy (CTE) is a progressive degenerative brain disease caused by repetitive head trauma. It is frequently found in athletes and military veterans who have a history of repetitive brain injury. The symptoms of CTE include memory loss, confusion, impaired judgment, impulse control problems, aggression, depression, and, eventually, progressive dementia. Most cases of CTE have been diagnosed at autopsy in individuals with a history of repetitive mild traumatic brain injury. CTE has been found in athletes who played football, hockey, soccer and other contact sports as well as military veterans who were exposed to explosive blasts.
The chronic traumatic encephalopathy market is estimated to be valued at USD 958 million in 2024 and is expected to reach USD 1,480 million by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
Key Takeaways
Key players operating in the chronic traumatic encephalopathy market are Brainscope, TetraScience, Neurona Therapeutics, BioDirection.
The key opportunities in the Chronic Traumatic Encephalopathy Market are increasing awareness about CTE, growing sports industry globally and development of new diagnostic methods and therapeutics for CTE.
Globally, the increasing participation in contact sports as well as rising number of military personnel exposed to repeated mild traumatic brain injuries is expected to drive the growth of chronic traumatic encephalopathy market across North America, Europe, Asia Pacific and RoW over the forecast period.
Market drivers
The major driver that is fueling the growth of the chronic traumatic encephalopathy market is increasing sports injuries. There has been a significant rise in the number of traumatic injuries in sports like American football, soccer, rugby and others owing to the high-impact collisions. Repeated mild traumatic brain injuries are the major cause of developing CTE later in life. With increasing participation in sports globally, especially in contact and collision sports, the incidence of sports-related concussions is also growing which is expected to drive the chronic traumatic encephalopathy market during the forecast period.
PEST Analysis
Political: Regulations regarding medical research and clinical trials play an important role in R&D for treatment of chronic traumatic encephalopathy. Government policies can facilitate or impede development of novel therapies.
Economic: Funding availability from public and private sources influences research into CTE prevention and management. Economic conditions also impact healthcare budgets and insurance coverage for advanced treatment options.
Social: Increased awareness about CTE and its links to contact sports raises social and ethical questions. Health advocacy efforts focus on player safety and management of neurological risks from repetitive head impacts.
Technological: Advancements in neuroimaging, biomarkers and other diagnostic tools aid understanding of CTE pathology. Development of innovative drugs and therapies relies on applications of technologies like gene engineering, drug delivery systems and regenerative medicine approaches.
Regions of concentration in terms of value
North America accounts for a major share of the global market value currently, due to rising research investments and healthcare spending in the United States and Canada. Prevalence of American football and enhanced diagnosis are contributing to the region's leading position.
Fastest growing region
Asia Pacific is projected to expand at the fastest pace over the coming years, driven by growing participation in contact/collision sports, increasing healthcare access and stronger focus on neurotrauma management in highly populated nations like China and India.
Get This Report in Japanese Language: 慢性外傷性脳症市場
Get This Report in Korean Language: 만성 외상성 뇌병증 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
